Lv6
1640 积分 2025-10-31 加入
Self-assembled nano-PROTACs potentiate colorectal cancer immunotherapy via downregulating PD-L1 and GPX4 expression
15天前
已完结
FDA Approval of the First-Ever PROTAC: Vepdegestrant (ARV-471) Marks a New Era in Targeted Protein Degradation
15天前
已完结
Development and Validation of Novel RP-HPLC Method for Determination of Assay and Related Substances of Flucytosine in Drug Product
28天前
已完结
Researches on Detection of Related Substances in Drugs
28天前
已完结
Development of a validated HPLC method for the quantitative determination of trelagliptin succinate and its related substances in pharmaceutical dosage forms
28天前
已完结
Related substances method development and validation of an LCMS/MS method for quantification of selexipag and its related impurities in rat plasma and its application to pharmacokinetic studies
28天前
已完结
Comprehensive Analytical Method Development for Related Substance Determination in Dorzolamide Hydrochloride-Timolol Maleate Ophthalmic Solutions: Multi-Method Approach and Regulatory Compliance
28天前
已完结
Development of APH003─a Highly Potent, Selective, and Orally Bioavailable IRAK4 PROTAC Degrader for the Treatment of Inflammatory Diseases
1个月前
已完结
A comprehensive mechanistic investigation of factors affecting intestinal absorption and bioavailability of two PROTACs in rats
1个月前
已完结
Evaluation of protein degradation by new proteolysis targeting chimera in human cervical adenocarcinoma epithelial cells and an in vivo mouse model
1个月前
已关闭
皖公网安备34019202002308
